SUBSCRIBE
SUBSCRIBE
News   Drug Development

Amylin Pharmaceuticals, Inc. Reports Positive Data from Byetta Study

December 15, 2009 | 
1 min read
Reuters -- Amylin Pharmaceuticals Inc (AMLN.O) reported positive data from a study that compared its experimental once-weekly form of its Byetta drug to its Byetta injection taken twice daily, in patients with type 2 diabetes.
Clinical research Postmarket research
MORE ON THIS TOPIC
Painful female periods concept. Vector flat character illustration. Woman standing and suffering menstrual abdominal pain isolated on pink background. Design for health care.
Women’s Health
Organon’s Endometriosis Drug Discontinued After Failing To Improve Pain
July 2, 2025
 · 
1 min read
 · 
Annalee Armstrong
IN PARTNERSHIP WITH IQVIA
Understanding the FDA’s AI Guidance in Pharmacovigilance
July 1, 2025
 · 
1 min read
 · 
Lori Ellis
Hand holding a nasal spray bottle against a white background
Psychedelics
Beckley’s Psychedelic Nasal Spray Clears Phase II Depression Study
July 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Collage with halftone hands putting puzzle together. Teamwork concept vector pop art retro style illustration. Partnership and relationship design element for infographic, poster, website
Rare diseases
FDA Signs Off on Neurogene’s ‘Best-Case Scenario’ Pivotal Study Design for Rett Syndrome
July 1, 2025
 · 
2 min read
 · 
Tristan Manalac